Location History:
- Gyeonggi-do, KR (2010 - 2014)
- Suwon-si, KR (2014 - 2015)
Company Filing History:
Years Active: 2010-2015
Title: **Innovative Contributions of Inventor Song Young Kim**
Introduction
Song Young Kim, an accomplished inventor based in Suwon-si, South Korea, has made significant contributions to the field of biotechnology, particularly in the development of modified proteins. With four patents to his name, his work focuses on enhancing the bioavailability and efficacy of therapeutic proteins.
Latest Patents
Among his latest inventions are two groundbreaking patents for modified human tumor necrosis factor receptor-1 (TNFR-1) polypeptides. The first patent relates to a TNFR-1 polypeptide that is engineered to be coupled with tumor necrosis factor, significantly improving its resistance against in vivo protease activity. This modification leads to enhanced bioavailability and absorption rate. The second patent similarly introduces a modified TNFR-1 polypeptide, which is capable of binding to tumor necrosis factor, showcasing improved binding affinity. These innovations hold promise for therapeutic applications in treating various diseases.
Career Highlights
Throughout his career, Song Young Kim has worked with renowned companies such as Hanall Biopharma Co., Ltd. and Daewoong Co., Ltd. His expertise and dedication have driven progress in biopharmaceutical development, particularly in the realm of therapeutic proteins.
Collaborations
Song Young Kim has collaborated with talented individuals in his field, including Seung Kook Park and Sung Wuk Kim. These partnerships have been instrumental in advancing his research and achieving successful patent outcomes.
Conclusion
In conclusion, Song Young Kim stands out as a leading inventor whose innovations in modified human TNFR-1 polypeptides are paving the way for more effective medical therapies. His work not only highlights the potential of protein engineering but also underscores the importance of collaboration in scientific advancement.